Download our app Order a test
News

Liquid biopsies “substantially improve” breast cancer diagnosis

Liquid biopsies have the potential to “substantially help to improve diagnosis” of breast cancer in women, a new study has found. Researchers writing in EBioMedicine (published by world-leading publisher The Lancet) found that “the clinical validity of liquid biopsy in the early breast cancer setting is more than evident.” Liquid biopsy techniques involve analysing a […]

Read more
News

Cancer gene testing could save millions of lives worldwide

Population-based screening for the BRCA genes that cause ovarian and breast cancer could save millions of lives a year, scientists have found. A new study, published in the journal Cancer, found that population-based genetic testing for BRCA 1 and BRCA 2 genes – where every woman over 30, regardless of risk-factor is screened – was […]

Read more

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more